Amarin | AMRN - 売上原価





売上原価 変化する 日付
AbbVie USD 4.22B 329M 2026-03
Alnylam Pharmaceuticals USD 267.72M 67.57M 2025-12
Amarin USD 26.05M 1.41M 2025-12
AstraZeneca USD -204M 3.48B 2026-03
BioCryst Pharmaceuticals USD 9.52M 7.34M 2025-12
Esperion Therapeutics USD 27.85M 13.43M 2025-12
GlaxoSmithKline GBP 1.88B 736M 2026-03
Halozyme Therapeutics USD 102.15M 29.14M 2025-12
Heron Therapeutics USD 11.12M 795K 2025-12
Ionis Pharmaceuticals USD 3M 5M 2026-03
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Neurocrine Biosciences USD 17.6M 246.4M 2025-12
Novartis USD 3.54B 3M 2025-12